Skip to main content
. 2010 Jan 29;116(1):8–22. doi: 10.1093/toxsci/kfq029

TABLE 3.

Clinical Chemistry Parameters of Male Wistar Rats after Repeated Administration of BI-2, BI-3, Gentamicin, or IMM125 for 1, 3, and 12 (urine) or 14 (serum) Days

Days of treatment BI-2
BI-3
Gentamicin
IMM125
0 mg/kg 2.5 mg/kg 15 mg/kg 0 mg/kg 100 mg/kg 1000 mg/kg 0 mg/kg 25 mg/kg 75 mg/kg 0 mg/kg 30 mg/kg 100 mg/kg
Urine
    Creatinine (mg/16 h) 1 4.3 3.9 4.4 ± 0.8 7.9 ± 1.3 8.5 ± 0.8 6.8 ± 1.6 2.4 ± 0.2 2.6 ± 0.3 2.3 ± 0.1 4.3 ± 1.1 4.7 ± 0.7 5.3 ± 0.7
3 5.1 ± 0.5 4.0 ± 0.0* 3.7 ± 0.1* 8.1 ± 1.5 8.9 ± 1.3 6.3 ± 1.1 2.7 ± 0.3 2.7 ± 0.3 2.6 ± 0.3 4.8 ± 1.4 5.5 ± 0.8 6.0 ± 1.1
12 5.6 ± 0.6 4.8 ± 0.7 4.5 ± 0.3 7.7 ± 1.2 7.7 ± 2.0 5.5 ± 1.8 3.9 ± 0.7 3.8 ± 0.6 3.8 ± 0.3 6.1 ± 1.0 6.9 ± 1.2 7.0 ± 0.6
    Protein (mg/mg creatinine) 1 Not determined 0.5 ± 0.1 0.5 ± 0.1 0.7 ± 0.6 1.0 ± 0.1 0.9 ± 0.2 1.1 ± 0.3 0.1 ± 0.1 0.5 ± 0.4 0.6 ± 0.5
3 Not determined 0.5 ± 0.1 0.7 ± 0.2 1.1 ± 0.9 1.0 ± 0.2 1.0 ± 0.3 1.3 ± 0.3 0.3 ± 0.2 0.3 ± 0.3 0.4 ± 0.7
12 Not determined 0.7 ± 0.6 1.1 ± 0.9 0.6 ± 0.4 1.4 ± 0.3 2.3 ± 0.7 2.7 ± 0.6* 0.4 ± 0.2 0.3 ± 0.1 0.5 ± 0.2
Serum
    Creatinine (mg/dl) 1 0.43 ± 0.13 0.42 ± 0.05 0.37 ± 0.06 0.51 ± 0.03 0.46 ± 0.03 0.47 ± 0.03 0.17 ± 0.02 0.16 ± 0.02 0.16 ± 0.02 0.28 ± 0.05 0.29 ± 0.07 0.22 ± 0.02
3 0.41 ± 0.04 0.44 ± 0.05 0.43 ± 0.07 0.52 ± 0.04 0.45 ± 0.04* 0.48 ± 0.04 0.19 ± 0.01 0.19 ± 0.04 0.21 ± 0.02 0.25 ± 0.04 0.27 ± 0.05 0.30 ± 0.08
14 0.46 ± 0.07 0.41 ± 0.05 0.45 ± 0.04 0.52 ± 0.07 0.53 ± 0.05 0.65 ± 0.32 0.21 ± 0.03 0.22 ± 0.03 0.26 ± 0.02* 0.32 ± 0.02 0.32 ± 0.04 0.35 ± 0.04
    BUN (mg/dl) 1 25 ± 3 27 ± 2 25 ± 2 49 ± 6 53 ± 17 46 ± 9 41 ± 4 39 ± 5 43 ± 6 13 ± 3 13 ± 4 13 ± 3
3 25 ± 4 28 ± 3 31 ± 7 50 ± 7 48 ± 7 67 ± 19 47 ± 7 46 ± 7 48 ± 7 14 ± 2 14 ± 3 15 ± 4
14 26 ± 2 26 ± 1 29 ± 4 45 ± 6 60 ± 6 110 ± 72 38 ± 6 41 ± 5 48 ± 4* 15 ± 1 17 ± 3 17 ± 3
    GGT (U/l) 1 0.40 ± 0.14 1.95 ± 2.19 0.18 ± 0.40 0.00 ± 0.00 0.01 ± 0.03 1.75 ± 1.38** < LOD < LOD < LOD 1.86 ± 1.90 1.02 ± 1.42 1.54 ± 2.21
3 1.00 ± 0.85 0.88 ± 0.29 0.35 ± 0.21 0.00 ± 0.00 0.00 ± 0.00 1.60 ± 2.44 < LOD < LOD < LOD 1.60 ± 3.58 2.54 ± 3.69 2.20 ± 3.73
14 1.15 ± 0.21 0.04 ± 0.09 0.62 ± 0.30 0.00 ± 0.00 0.00 ± 0.00 1.65 ± 1.31** < LOD < LOD < LOD 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
    Total protein (g/l) 1 55 ± 2 54 ± 4 54 ± 2 59 ± 1 58 ± 2 61 ± 2 54 ± 2 54 ± 2 54 ± 1 61 ± 1 58 ± 2* 56 ± 2**
3 55 ± 1 55 ± 1 53 ± 2 59 ± 1 58 ± 3 56 ± 3 56 ± 2 56 ± 1 57 ± 0 64 ± 2 59 ± 3* 52 ± 3***
14 56 ± 3 55 ± 2 52 ± 2* 58 ± 2 55 ± 2 45 ± 6*** 54 ± 1 55 ± 2 55 ± 3 64 ± 2 58 ± 2*** 53 ± 1***
    AST (U/l) 1 53 ± 12 61 ± 32 60 ± 12 193 ± 37 167 ± 38 298 ± 195 94 ± 18 93 ± 7 102 ± 12 132 ± 10 107 ± 13* 80 ± 17***
3 66 ± 14 75 ± 40 62 ± 8 190 ± 25 172 ± 22 215 ± 43 94 ± 10 91 ± 11 87 ± 15 108 ± 15 90 ± 10 69 ± 26*
14 62 ± 20 65 ± 9 62 ± 6 157 ± 19 151 ± 27 144 ± 40 89 ± 16 88 ± 19 97 ± 17 138 ± 22 95 ± 7** 72 ± 9***
    ALP (U/l) 1 99 ± 21 98 ± 10 104 ± 25 182 ± 25 149 ± 32 513 ± 289* 577 ± 129 536 ± 105 592 ± 156 213 ± 49.3 228 ± 61.8 191 ± 26
3 120 ± 30 87 ± 8* 89 ± 10* 197 ± 47 177 ± 36 425 ± 77*** 712 ± 179 666 ± 241 561 ± 169 245 ± 69.1 155 ± 27.1* 123 ± 12**
14 86 ± 17 87 ± 25 57 ± 5 114 ± 11 116 ± 13 262 ± 90** 510 ± 120 455 ± 94 398 ± 131 176 ± 20.5 116 ± 24.9** 95 ± 24***
    ALT (U/l) 1 26 ± 4 28 ± 8 27 ± 6 31 ± 5 28 ± 14 169 ± 185 25 ± 4 24 ± 5 23 ± 1 57 ± 9 49 ± 6 33 ± 12**
3 29 ± 6 45 ± 41 26 ± 7 24 ± 4 22 ± 2 43 ± 14** 24 ± 4 21 ± 2 22 ± 4 54 ± 11 22 ± 9*** 22 ± 6***
14 34 ± 15 30 ± 6 27 ± 2 24 ± 4 28 ± 10 24 ± 4 26 ± 5 24 ± 2 31 ± 10 52 ± 7 46 ± 8 34 ± 8**
    Bilirubin (mg/dl) 1 0.10 ± 0.02 0.09 ± 0.05 0.09 ± 0.02 Not determined 0.08 ± 0.02 0.08 ± 0.02 0.08 ± 0.01 0.07 ± 0.02 0.09 ± 0.02 0.17 ± 0.05**
3 0.11 ± 0.04 0.11 ± 0.03 0.11 ± 0.01 Not determined 0.08 ± 0.01 0.07 ± 0.01 0.09 ± 0.01 0.09 ± 0.03 0.14 ± 0.03 0.45 ± 0.10***
14 0.07 ± 0.03 0.04 ± 0.02 0.06 ± 0.02 Not determined 0.06 ± 0.02 0.08 ± 0.02 0.09 ± 0.01* 0.10 ± 0.03 0.17 ± 0.02* 0.28 ± 0.07***
    Glucose (mg/dl) 1 175 ± 14 188 ± 9 180 ± 29 147 ± 11 132 ± 23 152 ± 20 123 ± 9 119 ± 14 122 ± 13 95 ± 16 114 ± 12 120 ± 23
3 154 ± 9 176 ± 17* 169 ± 13 144 ± 20 143 ± 8 122 ± 6* 138 ± 22 126 ± 16 132 ± 12 74 ± 4 84 ± 9 101 ± 14**
14 171 ± 35 191 ± 21 192 ± 14 148 ± 14 163 ± 4 128 ± 47 123 ± 25 117 ± 12 130 ± 11 80 ± 14 92 ± 15 111 ± 8**

Note. Data are presented as mean ± SD (n = 5). Statistical analysis was performed by ANOVA and Dunnett’s post hoc test; LOD, limit of detection.

*p < 0.05, **p < 0.01, and ***p < 0.001.